Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13446712 | 0.87 | ALDH1A1 (0.35) | SMN1; SMN2KMT2AALDH1A1 | |
| SCHEMBL275279 | 0.81 | SMN1; SMN2 (0.48) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL2727651 | 0.74 | SMN1; SMN2 (0.42) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL25657379 | 0.74 | SMN1; SMN2 (0.42) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL276322 | 0.74 | KMT2A (0.43) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL12703338 | 0.72 | SMN1; SMN2 (0.42) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL18609320 | 0.72 | SMN1; SMN2 (0.42) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL2289696 | 0.72 | SMN1; SMN2 (0.40) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL5840367 | 0.72 | SMN1; SMN2 (0.40) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL5196342 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112888696-A | Exonucleotidase inhibitors and methods of use thereof | 卡利泰拉生物科技公司 | 2021-06-01 | — | — | CN | disclosed |